Portfolio company
Hijack Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops biotherapeutic drug delivery systems using engineered bacteria to enable the production and delivery of programmable living therapies for pharmaceutical customers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Laguna Bio
This company develops engineered microbial therapies that activate the immune system to treat cancer patients.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
Ancilia Bio
The company develops CRISPR-engineered bacterial therapies with viral immunity for the biopharmaceutical and healthcare sectors.
Think Bioscience
This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
Neobe
The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
